Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle
- PMID: 7856099
- DOI: 10.1006/viro.1995.1009
Efficient EBV superinfection of group I Burkitt's lymphoma cells distinguishes requirements for expression of the Cp viral promoter and can activate the EBV productive cycle
Abstract
Group I Burkitt's lymphoma cell lines conditionally expressing the CD21 receptor for EBV infection were superinfected with EBV. The incoming EBV entered its normal program of gene expression, producing EBNA-2 and LMP-1 and activating the Cp EBNA promoter, but the endogenous virus in the BL lines was not induced to express EBNA-2 or transcribe RNA from Cp. LMP-1 was, however, expressed from the endogenous genome in response to superinfection. In a proportion of the superinfected Akata cells, the productive cycle antigen BZLF1 was induced and the ability of infecting virus to cause this was sensitive to inactivation by uv light. The results show that the restricted latent pattern of EBV gene expression observed in Group I BL cells is not a consequence of lack of appropriate transcription factor activity but results from inactivation of part of the viral genome, probably by methylation. Induction of BZLF1 in some of the cells also indicates a novel pathway for activation of the virus productive cycle.
Similar articles
-
Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.J Med Virol. 2003 Jul;70(3):410-9. doi: 10.1002/jmv.10411. J Med Virol. 2003. PMID: 12767005
-
Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.Virology. 1993 Apr;193(2):774-85. doi: 10.1006/viro.1993.1186. Virology. 1993. PMID: 8384755
-
Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.J Med Virol. 1998 Jul;55(3):219-26. J Med Virol. 1998. PMID: 9624610
-
The molecular biology of Epstein-Barr virus.Biomed Pharmacother. 1985;39(2):59-66. Biomed Pharmacother. 1985. PMID: 2990591 Review.
-
Cell death suffers a TKO.Bioessays. 1995 Jun;17(6):557-9. doi: 10.1002/bies.950170614. Bioessays. 1995. PMID: 7575499 Review.
Cited by
-
Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.J Virol. 1999 Apr;73(4):2974-82. doi: 10.1128/JVI.73.4.2974-2982.1999. J Virol. 1999. PMID: 10074147 Free PMC article.
-
Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.J Virol. 2012 Jan;86(2):1034-45. doi: 10.1128/JVI.05923-11. Epub 2011 Nov 9. J Virol. 2012. PMID: 22072770 Free PMC article.
-
Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs.Mol Cell Biol. 1997 Jan;17(1):364-77. doi: 10.1128/MCB.17.1.364. Mol Cell Biol. 1997. PMID: 8972217 Free PMC article.
-
Mapping promoter regions that are hypersensitive to methylation-mediated inhibition of transcription: application of the methylation cassette assay to the Epstein-Barr virus major latency promoter.J Virol. 1997 Sep;71(9):6445-54. doi: 10.1128/JVI.71.9.6445-6454.1997. J Virol. 1997. PMID: 9261362 Free PMC article.
-
Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.J Virol. 2007 Jan;81(2):1037-42. doi: 10.1128/JVI.01416-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079287 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Miscellaneous